U.S. Securities and Exchange Commission

Washington, D.C. 20549

 

Form 8-K/A

 

Current Report

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

 

April 27, 2010

Date of Report (Date of earliest event Reported)

 

MESA LABORATORIES, INC.
(Exact Name of Small Business Issuer as Specified in its Charter)

 

Commission File Number: 0-11740

 

COLORADO

 

84-0872291

(State or other Jurisdiction of
Incorporation or Organization)

 

(I.R.S. Employer
Identification No.)

 

12100 WEST SIXTH AVENUE, LAKEWOOD,
COLORADO

 

80228

(Address of Principal Executive Offices)

 

(Zip Code)

 

Issuer’s telephone number, including area code: (303) 987-8000

 

Not Applicable.

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

ON MAY 3, 2010, THE REGISTRANT FILED A CURRENT REPORT ON FORM 8-K RELATING TO ITS ACQUISITION OF SGM BIOTECH, INC. THE PURPOSE OF THE AMENDMENT IS TO PROVIDE THE FINANCIAL STATEMENTS AND INFORMATION REQUIRED BY ITEM 9.01 OF THE FORM 8-K.

 

Item 9.01               Financial Statements and Exhibits

 

(a)           Financial Statements of Businesses Acquired.

 

The Audited Consolidated Financial Statements of SGM Biotech, Inc. and Affiliate for the years ended December 31, 2009 and 2008 is attached as Exhibit 99.2.

 

(b)           Pro Forma Financial Information.

 

The Unaudited Pro Forma Condensed Consolidated Balance Sheet of Registrant as of March 31, 2010 and the Unaudited Pro Forma Condensed Consolidated Statement of Income of Registrant for the fiscal year ended March 31, 2010 are attached as Exhibit 99.3.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

MESA LABORATORIES, INC.

 

(Issuer)

 

 

 

DATED: July 12, 2010

BY:

/s/ John J. Sullivan

 

 

 

 

 

John J. Sullivan, Ph.D.

 

 

Chief Executive Officer,
President, Treasurer and Director

 

 

INDEX TO EXHIBITS

 

Exhibit No.

 

Description

 

Method of Filing

 

 

 

 

 

99.1

 

Press release dated April 27, 2010

 

Previously Filed

 

2